| Mechanisms of chemoresistance to alkylating agents in malignant glioma JN Sarkaria, GJ Kitange, CD James, R Plummer, H Calvert, M Weller, ... Clinical cancer research 14 (10), 2900-2908, 2008 | 440 | 2008 |
| Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts GJ Kitange, BL Carlson, MA Schroeder, PT Grogan, JD Lamont, ... Neuro-oncology 11 (3), 281-291, 2009 | 398 | 2009 |
| Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177 PD Brown, S Krishnan, JN Sarkaria, W Wu, KA Jaeckle, JH Uhm, ... Journal of Clinical Oncology 26 (34), 5603, 2008 | 318 | 2008 |
| Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response JN Sarkaria, BL Carlson, MA Schroeder, P Grogan, PD Brown, C Giannini, ... Clinical cancer research 12 (7), 2264-2271, 2006 | 290 | 2006 |
| A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma X Chen, M Zhang, H Gan, H Wang, JH Lee, D Fang, GJ Kitange, L He, ... Nature communications 9 (1), 2949, 2018 | 227 | 2018 |
| Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel JN Sarkaria, L Yang, PT Grogan, GJ Kitange, BL Carlson, MA Schroeder, ... Molecular cancer therapeutics 6 (3), 1167-1174, 2007 | 212 | 2007 |
| p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells L Cen, BL Carlson, MA Schroeder, JL Ostrem, GJ Kitange, AC Mladek, ... Neuro-oncology 14 (7), 870-881, 2012 | 204 | 2012 |
| Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts GJ Kitange, AC Mladek, BL Carlson, MA Schroeder, JL Pokorny, L Cen, ... Clinical Cancer Research 18 (15), 4070-4079, 2012 | 155 | 2012 |
| The role of LAT1 in 18F-DOPA uptake in malignant gliomas RS Youland, GJ Kitange, TE Peterson, DH Pafundi, JA Ramiscal, ... Journal of neuro-oncology 111, 11-18, 2013 | 149 | 2013 |
| Recent advances in the molecular genetics of primary gliomas GJ Kitange, KL Templeton, RB Jenkins Current opinion in oncology 15 (3), 197-203, 2003 | 145 | 2003 |
| Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma RA Vaubel, S Tian, D Remonde, MA Schroeder, AC Mladek, GJ Kitange, ... Clinical Cancer Research 26 (5), 1094-1104, 2020 | 135 | 2020 |
| Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma SK Gupta, SH Kizilbash, BL Carlson, AC Mladek, F Boakye-Agyeman, ... Journal of the National Cancer Institute 108 (5), djv369, 2016 | 130 | 2016 |
| DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme ZD Nagel, GJ Kitange, SK Gupta, BA Joughin, IA Chaim, P Mazzucato, ... Cancer research 77 (1), 198-206, 2017 | 122 | 2017 |
| Impairment of glioma stem cell survival and growth by a novel inhibitor for survivin–ran protein complex H Guvenc, MS Pavlyukov, K Joshi, H Kurt, YK Banasavadi-Siddegowda, ... Clinical Cancer Research 19 (3), 631-642, 2013 | 107 | 2013 |
| Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas G Kitange, A Misra, M Law, S Passe, TM Kollmeyer, M Maurer, K Ballman, ... Genes, Chromosomes and Cancer 42 (1), 68-77, 2005 | 106 | 2005 |
| Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model GJ Kitange, BL Carlson, AC Mladek, PA Decker, MA Schroeder, W Wu, ... Journal of Neuro-oncology 92, 23-31, 2009 | 102 | 2009 |
| Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts BL Carlson, PT Grogan, AC Mladek, MA Schroeder, GJ Kitange, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 212-219, 2009 | 100 | 2009 |
| Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. G Kitange, S Shibata, Y Tokunaga, N Yagi, A Yasunaga, M Kishikawa, ... Laboratory investigation; a journal of technical methods and pathology 79 (4 …, 1999 | 87 | 1999 |
| Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance GJ Kitange, BL Carlson, MA Schroeder, PA Decker, BW Morlan, W Wu, ... Journal of neuro-oncology 100, 177-186, 2010 | 84 | 2010 |
| Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines ME Law, KL Templeton, G Kitange, J Smith, A Misra, BG Feuerstein, ... Cancer genetics and cytogenetics 160 (1), 1-14, 2005 | 83 | 2005 |
